So, the other day, like two days ago, >> Yes. >> you said you're going to buy the XBI, which yesterday I updated our viewers and said that you did. Yes.>> Followed through on that. Now, you're buying more. >> Yes.>> Already. >> Yes. >> Why.Because you buy high and you sell higher in particular when you get a breakout, a multi-year breakout. The November of 2024 high, we talked about that yesterday. The potential for the XBI to exceed that price level.In fact, that's what it has done this morning. So, you ad ...

Core Viewpoint - The healthcare sector is experiencing a significant turnaround, with a notable increase in large-cap healthcare ETFs, indicating a potential shift towards quality investments in the industry [1][2]. Group 1: Market Sentiment and Investment Strategies - The recent Pfizer deal has generated positive sentiment in the healthcare space, leading to increased bullishness and new investments in companies like Merck [2][11]. - There is a belief that the market will shift from momentum-based investments to quality-focused investments, particularly in healthcare [2][3]. - The XBI ETF is seen as a promising investment opportunity, with expectations of a multi-year breakout [3][9]. Group 2: Industry Challenges and Opportunities - The healthcare system is perceived as "broken," similar to the technology sector during the rise of the internet, suggesting that technology-driven companies will thrive [5][6]. - Companies like Viva Systems, which leverage technology in healthcare, are expected to succeed as the industry transitions to value-based care models [6][8]. - The pharmaceutical sector faces challenges, particularly larger companies needing to discover new drugs, but recent events may have created a more favorable investment environment [10][11]. Group 3: Investment Preferences and Risks - There is a preference for investing in contract research organizations that support pharmaceutical and biotech companies, avoiding direct drug risk [12]. - The medtech field is gaining interest, particularly companies utilizing 3D printing for orthopedic implants, indicating innovation within the sector [13].

Healthcare coming off its best week since June of 2022. Now BTIG's Jonathan Krinsky looks at that turn and says the breakout feels different. Maybe it feels different this time.The large cap healthcare ETF, it's the XLV best 5day gain. What do we think, Joe. You have a pretty good amount of exposure here.We had the the Fizer deal announced and that led to a lot of good feeling in this space for the first time in a long time. those you know reasons to be more bullish overall now led me to buy Merc have a new ...

Group 1 - SoFi shares have reached an all-time high, with expectations for upgrades to boost the stock price in the coming week [1] - Clearway Energy is highlighted for its 6.5% dividend yield, with a focus on growing earnings and dividends despite market rhetoric about clean energy [2] - The healthcare sector within small caps is noted, with a significant weighting of 16% in the IWM index [2] Group 2 - CrowdStrike's stock has increased by $50, indicating strong market performance [2]

Market Performance - In July, global stock markets showed a mixed performance, with the US indices collectively rising, led by the Nasdaq, while the Dow remained flat[3] - The UK FTSE 100 outperformed the Nasdaq, and the VN30 index in Vietnam led the gains in the Asia-Pacific region[3] Economic Indicators - The US non-farm payrolls for July showed an increase of only 73,000 jobs, significantly below the expected 110,000, with prior months' figures revised down by a total of 258,000 jobs[3] - The probability of a Federal Reserve rate cut in September has surged to over 80%, with a 50% chance of another cut in October[3] Federal Reserve Outlook - Internal divisions within the Federal Reserve are evident, with two dissenting votes in the recent FOMC meeting and a key member announcing an early resignation[3] - The likelihood of a dovish shift from the Fed has increased, with expectations of a 50-75 basis point rate cut in the remaining months of the year[3] Investment Strategy - The report suggests focusing on interest rate cut trades and opportunities in the US stock market following potential corrections[3] - Short-term bonds are favorable, but long-term bonds may offer greater advantages due to duration and declining inflation[3] Risk Factors - Potential risks include unexpected rebounds in overseas inflation, weaker-than-expected global economic conditions, and escalated geopolitical tensions[3]

Economic Outlook - The US is at the tail end of an economic recovery cycle while entering a new AI technology phase, with capital expenditure in the AI sector stabilizing[3] - Short-term market impacts are expected to be limited, with focus remaining on economic cycles, tariffs, fiscal policies, and geopolitical situations in the second half of 2025[3] Tariff Analysis - As of May, US tariff revenue was $22.17 billion, annualizing to approximately $266 billion, significantly lower than Navarro's estimate of $600 billion[3] - The weighted average tariff rate is projected to rise to 16.1%, potentially generating $665.91 billion in annual tariff revenue based on 2024 import levels of $4.1 trillion[3] - Tariff impacts on inflation may begin to manifest in Q3, with historical data suggesting a high pass-through rate to consumers[3] Fiscal Stability - The overall fiscal impact from the "Big Beautiful Bill" is expected to be limited, with a projected increase in the federal deficit of approximately $2.8 trillion over the next decade, but most of this will not materialize in 2025[3] - The expected interest expenditure in May was $86 billion, indicating significant ongoing fiscal pressures[3] - The upcoming maturity of US debt is not substantial, reducing concerns over debt sustainability in the near term[3] Geopolitical Risks - Geopolitical tensions, particularly in the Middle East, could lead to significant inflationary pressures and complicate the Federal Reserve's monetary policy decisions[3] - Two scenarios are outlined: one where escalating tensions lead to higher oil prices and potential stagflation, and another where stabilization allows for possible interest rate cuts by the Fed[3] Investment Strategy - The report suggests focusing on volatility trading strategies using tools like VIX and SIV, and considering domestic companies benefiting from reduced foreign competition due to tariffs[3] - In a stagflation scenario, commodities like gold may perform well, while in a shallow recession scenario, small-cap growth stocks and long-term US Treasuries may be favored[3] Risk Factors - Global economic performance may underperform expectations, leading to pressure on US equities and other risk assets[3] - Inflation could prove stickier than anticipated, complicating the Fed's rate-cutting plans[3] - Escalation of geopolitical conflicts could trigger rapid market volatility and inflationary pressures[3]

以下文章来源于配置实战 ，作者配置实战 配置实战 . 机构资产配置的一线认知。 摘要：市场出现结构性改变时，配置者要有魄力推动转变。 本文由配置 实战iPortfolio原创 本期「配置实战iPortfolio」，我们和对冲基金FOF投资人Harvey聊了聊FOF配置对冲基金的理由、 策略和模式创新，最后聊了聊香港。 本期参与讨论的嘉宾刘敏（Harvey），是Harview创始人兼首席投资官。在2024年创立Harview之 前，刘敏曾是弘源对冲基金组合负责人，投资委会成员。2015年加入弘源之前，担任承誉资本副总 裁，负责全球多资产类别配置以及对冲基金投资。加入承誉资本之前，刘敏就职于中金公司，参与了 中金与英国对冲基金Sloane Robinson联合创办的大中华股票多空对冲基金，投资中国股票。 以下是对本期对话内容（有删节，内容仅供参考，不构成任何投资建议）： D=Deyang，配置实战iPortfolio主播 M=Mason，配置实战iPortfolio主播 H=Harvey，Harview创始人兼首席投资官 1.认识嘉宾：持续做FOF投资的认知和感受 D：从十几年的对冲基金FOF经历中，你认为FOF ...